Article
Gifts To Referral Sources And Patients
At this time of year, healthcare providers may want to give gifts to patients, referring providers, or other sources of business.
Holland & Hart
Food, Drugs, Healthcare, Life Sciences
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
An Overview Of The Over-the-Counter Monograph Drug User Fee Amendments (OMUFA): Policy Areas To Watch
On November 12, 2025, President Trump signed H.R. 5371, the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026...
Akin Gump Strauss Hauer & Feld LLP
Article
Telehealth And Hospital-at-Home Rules Reinstated After October Lapse; DEA Signals Extension Of Telemedicine Prescribing Flexibilities
On Nov. 12, 2025, President Trump signed a short-term federal spending bill that restores key Medicare telehealth and Acute Hospital Care at Home (Hospital-at-Home) flexibilities through Jan. 30, 2026.
Polsinelli LLP
Article
Vera Therapeutics Submits BLA To FDA For Atacicept Fusion Protein
On November 7, Vera Therapeutics announced that it submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) through the Accelerated Approval Program for atacicept for the treatment...
Goodwin Procter LLP
Article
New OTC Drug And Sunscreen Provisions Passed In Congress
Perkins Coie LLP
Article
2025 Update On Plant Biostimulant Product Regulation Under FIFRA
Beveridge & Diamond
Article
Answering The Call For Prior Authorization Reform
Jones Walker
Article
FDA's New "Plausible Mechanism Pathway" And Other Initiatives To Expedite Approval Of Drugs For Ultra-Rare Conditions
Arnold & Porter
Article
FDA Approves Shanghai Henlius's Interchangeable Pertuzumab Biosimilar
Goodwin Procter LLP
Article
FDA Seeks Guidance From The Digital Health Advisory Committee On AI: Considerations For Innovators Of Digital Mental Health Medical Devices And Wellness Products
BakerHostetler
Article
AI-Enabled Care Is On The Rise For Medicare Beneficiaries—What Payors And Providers Need To Know
Manatt, Phelps & Phillips LLP
Podcast
Album 9, Track 11: Steady On - Trilliant Health (Part 1) (Podcast)
Polsinelli LLP
Article
Food Venture Financing News – Weekly Issue No. 261
Davis Wright Tremaine
Article
Unlocking Bespoke Product Approvals: FDA Puts Forth Plausible Mechanism Pathway
Katten Muchin Rosenman LLP
Webinars
See MoreWebinar
Recorded on 24 Jun 2025 | 3:00 PM
(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession
In-House Counsel Worldwide
Webinar
Recorded on 24 Jun 2025 | 9:00 AM
(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession
In-House Counsel Worldwide
Webinar
Recorded on 30 Apr 2025 | 2:00 PM
Mondaq | 2025 Law Firm Data Landscape Report
Mondaq
Webinar
Recorded on 21 Jan 2025 | 3:00 PM
2025 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CCCA | Mondaq
CBA In-House Lawyers
Highlighted Content
Curated
Plausibility At The EPO – An Update On G2/21
Dehns
Curated
Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?
Dehns
Curated
Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?
Dehns
Curated
How Good Does A Copy Need To Be?
Dehns
Curated
Supplementary Protection Certificates – European Patent Term Extensions
Dehns
Curated
How Much Experimental Data Is Needed For Patent Applications In Europe?
Dehns
Curated
The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects
Dehns
Curated
Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector
Dehns
Curated
Protection For Plant Varieties In Europe And The UK Post-Brexit
Dehns
Curated
Best Practice For Invention Harvesting
Dehns
Article
Gifts To Referral Sources And Patients
At this time of year, healthcare providers may want to give gifts to patients, referring providers, or other sources of business.
Holland & Hart
Article
Employers Grapple With GLP-1 Coverage For Weight Loss
Whether and how to cover GLP-1 medications for weight loss is a challenging issue for many employers. As obesity rates remain high in many states, employers are making tough decisions...
Ogletree, Deakins, Nash, Smoak & Stewart
Article
Telehealth And Hospital-at-Home Rules Reinstated After October Lapse; DEA Signals Extension Of Telemedicine Prescribing Flexibilities
On Nov. 12, 2025, President Trump signed a short-term federal spending bill that restores key Medicare telehealth and Acute Hospital Care at Home (Hospital-at-Home) flexibilities through Jan. 30, 2026.
Polsinelli LLP
Article
Medical Debt In Credit Reports: What Employers Need To Know Amid Legal Shifts
Ogletree, Deakins, Nash, Smoak & Stewart
Article
This Week From The Hill (November 16 – 22, 2025)
Groom Law Group
Article
Why Your Health Insurance's Advance Health Care Directive Isn't Enough
TLD Law
Article
Answering The Call For Prior Authorization Reform
Jones Walker
Article
Tips For Employers To Stay Compliant With Privacy Protections Under HIPAA, ADA, And 42 CFR Part 2
Ogletree, Deakins, Nash, Smoak & Stewart
Article
After The Shutdown
Greenberg Traurig, LLP
Article
From Great Idea To Market Success With Patricia W. Peiffer (Podcast)
From Lab to Patient, Garage to Market with Philip Crowley, Episode 27.
Crowley Law LLC
Article
FDA's Move To Streamline Biosimilar Approval: What In-House Counsel Must Prepare For Now
On 29 Oct. 2025, FDA released a new draft guidance (on the need for demonstrating comparative clinical efficacy studies) signaling a major shift in biosimilar regulation.
Upadhye Tang
Article
2025 Update On Plant Biostimulant Product Regulation Under FIFRA
Growing interest in sustainable agriculture has increased demand for plant biostimulant products that enhance natural plant processes to improve crop performance. In general, plant biostimulant products refer to biological...
Beveridge & Diamond
Article
New Continuation Fee Among 2025 USPTO Changes Impacting Biotech
Polsinelli LLP
Article
FDA's New "Plausible Mechanism Pathway" And Other Initiatives To Expedite Approval Of Drugs For Ultra-Rare Conditions
Arnold & Porter
Article
FDA Seeks Guidance From The Digital Health Advisory Committee On AI: Considerations For Innovators Of Digital Mental Health Medical Devices And Wellness Products
BakerHostetler
Article
New USPTO IDS Fees Raise Strategic Stakes For Biotech Filings
Polsinelli LLP
Article
Needle Little Transparency: Alabama AG Targets Research-Grade GLP-1s
Cozen O'Connor
Article
New FDA Guidance Aims To Simplify The Biosimilar Approval Process
Goodwin Procter LLP
Article
IEEPA Reciprocal Tariff Product Exclusions Expanded To Food, Fertilizer
Effective for entries made on or after November 13, 2025, the list of goods exempted from reciprocal tariffs has been expanded to include certain meat, vegetables...
Cassidy Levy Kent
Article
Employers Grapple With GLP-1 Coverage For Weight Loss
Whether and how to cover GLP-1 medications for weight loss is a challenging issue for many employers. As obesity rates remain high in many states, employers are making tough decisions...
Ogletree, Deakins, Nash, Smoak & Stewart
Article
An Overview Of The Over-the-Counter Monograph Drug User Fee Amendments (OMUFA): Policy Areas To Watch
On November 12, 2025, President Trump signed H.R. 5371, the Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026...
Akin Gump Strauss Hauer & Feld LLP
Article
Major Pasta Recall Illustrates Issues That Could Arise Under Food Contamination Insurance Policies
Cozen O'Connor
Article
Vera Therapeutics Submits BLA To FDA For Atacicept Fusion Protein
Goodwin Procter LLP
Article
New OTC Drug And Sunscreen Provisions Passed In Congress
Perkins Coie LLP
Article
FDA's New "Plausible Mechanism Pathway" And Other Initiatives To Expedite Approval Of Drugs For Ultra-Rare Conditions
Arnold & Porter
Article
FDA Approves Shanghai Henlius's Interchangeable Pertuzumab Biosimilar
Goodwin Procter LLP
Article
FDA Seeks Guidance From The Digital Health Advisory Committee On AI: Considerations For Innovators Of Digital Mental Health Medical Devices And Wellness Products
BakerHostetler
See more
Navigating Health Plan M&A: Strategies For Success In The Medicare Advantage Market (Podcast)
Ropes & Gray LLP
WHLC Summit - Day One Recording (Video)
Sheppard Mullin Richter & Hampton
Redefining Healthcare Leadership: Dr. Heather Farley On The Inaugural Role Of Chief Well-being Officer At MUSC (Video)
Alvarez & Marsal
Navigating Women's Health With Rachel Welch (Video)
Offit Kurman
Inside MedTech Translation Challenges: Ensuring Multilingual Regulatory Compliance
Moringside
Upcoming Events
Webinar
18 Dec 2025
Top Take-Aways From CMS’ Final 2026 OPPS, PFS, IPPS Rules
Foley & Lardner
Conference
10 Dec 2025
ATA EDGE 2025 Policy Conference
Foley & Lardner
Conference
8 Dec 2025
TSCPA Health Care Conference
Bass, Berry & Sims
Panel
4 Dec 2025
Barracuda Bowl 2025
Mintz
Panel
3 Dec 2025
8th Annual Summit On Life Sciences IP Due Diligence
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Roundtable
29 Jan 2026
Pharmaceutical EHS Counsel Roundtable
Beveridge & Diamond
Webinar
9 Dec 2025
The GENEROUS Model: What It Means For Life Science Companies, States And Patients
Manatt, Phelps & Phillips LLP
Webinar
2 Dec 2025
Bridging US Market Access In Bio Sciences And Cosmetics: From Partnership To Deployment
Mintz